Editas Medicine Ownership | Who Owns Editas Medicine?


OverviewForecastRevenueFinancialsChartTranscripts

Editas Medicine Ownership Summary


Editas Medicine is owned by 52.98% institutional investors, 0.35% insiders, and 46.67% retail investors. Blackrock is the largest institutional shareholder, holding 9.50% of EDIT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.12% of its assets in Editas Medicine shares.

EDIT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEditas Medicine52.98%0.35%46.67%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock7.78M9.50%$36.34M
Blackrock funding, inc. /de7.31M8.86%$9.28M
Vanguard group6.82M8.27%$8.67M
Millennium management2.75M3.33%$3.49M
Dimensional fund advisors lp2.16M2.62%$2.74M
State street1.87M2.27%$2.38M
Geode capital management1.81M2.19%$2.30M
Goldman sachs group1.79M2.17%$2.27M
Two sigma advisers, lp1.66M2.01%$2.10M
Two sigma investments, lp1.65M2.00%$2.09M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Green alpha advisors111.63K0.11%$141.77K
Hennion & walsh asset management267.76K0.02%$340.05K
Kennedy capital management528.84K0.01%$671.62K
Dlk investment management25.72K0.01%$32.66K
Xtx topco105.06K0.01%$133.42K
Thrive wealth management28.50K0.01%$36.20K
Dark forest capital management lp32.79K0.01%$41.64K
Two sigma advisers, lp1.66M0.00%$2.10M
Susquehanna fundamental investments272.43K0.00%$345.99K
Aries wealth management13.85K0.00%$17.59K

Top Buyers

HolderShares% AssetsChange
Renaissance1.45M0.00%1.45M
Ubs group1.12M0.00%704.47K
Aqr capital management1.07M0.00%693.96K
Goldman sachs group1.79M0.00%619.01K
Two sigma advisers, lp1.66M0.00%528.00K

Top Sellers

HolderShares% AssetsChange
Deep track capital, lp---4.90M
Avidity partners management lp---1.47M
Balyasny asset management---1.30M
Pictet asset management sa---1.16M
Monaco asset management sam---1.07M

New Positions

HolderShares% AssetsChangeValue
Susquehanna fundamental investments272.43K0.00%272.43K$345.99K
Raymond james financial238.97K0.00%238.97K$303.49K
Acadian asset management193.59K0.00%193.59K$244.00K
Bridgeway capital management150.00K0.00%150.00K$190.50K
Sei investments83.16K0.00%83.16K$105.61K

Sold Out

HolderChange
Gps wealth strategies group-2.00
Pacific capital wealth advisors-5.00
Sittner & nelson-6.00
Baldwin brothers llc/ma-8.00
Abich financial wealth management-12.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025196-6.67%44,003,328-13.78%521.38%69-27.37%59-1.67%
Dec 31, 202494-60.17%19,933,396-63.85%240.54%38-62.00%22-65.63%
Sep 30, 2024234-2.50%55,137,509-2.17%661.43%100-10.71%64-12.33%
Jun 30, 20242382.15%56,360,093-17.01%680.86%111-7116.39%
Mar 31, 20242330.87%67,911,28916.06%891.74%11116.84%61-12.86%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF2.59M3.12%-
Vanguard Total Stock Mkt Idx Inv2.59M3.10%-
iShares Russell 2000 ETF2.12M2.53%1.04K
Vanguard Strategic Equity Inv1.87M2.24%498.30K
Vanguard Institutional Extnd Mkt Idx Tr1.37M1.63%-
Pictet Biopharmaceutical Mother1.15M1.38%42.67K
Selectra J. Lamarck Biotech A1.10M1.32%600.00K
Vanguard Small Cap Index1.04M1.26%2.50K
Fidelity Small Cap Index832.05K0.99%-
UBS (Lux) Digital Health Equity SB USD800.00K0.96%-370.00K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 03, 2025Parison Amy SVP, Chief Financial OfficerSell$768.90
Jun 03, 2025Burkly Linda EVP, CHIEF SCIENTIFIC OFFICERSell$1.25K
Jun 03, 2025O'Neill Gilmore Neil CEOSell$26.20K
Mar 04, 2025Lucera Erick EVP, CHIEF FINANCIAL OFFICERSell$7.03K
Mar 04, 2025O'Neill Gilmore Neil CEOSell$28.45K

Insider Transactions Trends


DateBuySell
2025 Q2-3
2025 Q1-3
2024 Q4-2
2024 Q3-4
2024 Q213

EDIT Ownership FAQ


Who Owns Editas Medicine?

Editas Medicine shareholders are primarily institutional investors at 52.98%, followed by 0.35% insiders and 46.67% retail investors. The average institutional ownership in Editas Medicine's industry, Biotech Stocks , is 63.96%, which Editas Medicine falls below.

Who owns the most shares of Editas Medicine?

Editas Medicine’s largest shareholders are Blackrock (7.78M shares, 9.50%), Blackrock funding, inc. /de (7.31M shares, 8.86%), and Vanguard group (6.82M shares, 8.27%). Together, they hold 26.63% of Editas Medicine’s total shares outstanding.

Does Blackrock own Editas Medicine?

Yes, BlackRock owns 9.50% of Editas Medicine, totaling 7.78M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 36.34M$. In the last quarter, BlackRock decreased its holdings by -50.264K shares, a -0.64% change.

Who is Editas Medicine’s biggest shareholder by percentage of total assets invested?

Green alpha advisors is Editas Medicine’s biggest shareholder by percentage of total assets invested, with 0.11% of its assets in 111.63K Editas Medicine shares, valued at 141.77K$.

Who is the top mutual fund holder of Editas Medicine shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Editas Medicine shares, with 3.12% of its total shares outstanding invested in 2.59M Editas Medicine shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools